Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Correlation of natural autoantibodies and cardiovascular disease-related anti-bacterial antibodies in pericardial fluid of cardiac surgery patients.

Simon D, Gilicze O, Farkas N, Najbauer J, Németh P, Lénárd L, Berki T.

Clin Exp Immunol. 2018 Jul;193(1):55-63. doi: 10.1111/cei.13127.

PMID:
29573404
2.

Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.

Ugor E, Prenek L, Pap R, Berta G, Ernszt D, Najbauer J, Németh P, Boldizsár F, Berki T.

Immunobiology. 2018 Apr - May;223(4-5):422-431. doi: 10.1016/j.imbio.2017.10.010. Epub 2017 Oct 6.

3.

Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis.

Ugor E, Simon D, Almanzar G, Pap R, Najbauer J, Németh P, Balogh P, Prelog M, Czirják L, Berki T.

Clin Immunol. 2017 Nov;184:54-62. doi: 10.1016/j.clim.2017.05.013. Epub 2017 May 15.

PMID:
28522286
4.

Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ, Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen M, Aboody KS.

Clin Cancer Res. 2017 Jun 15;23(12):2951-2960. doi: 10.1158/1078-0432.CCR-16-1518. Epub 2016 Dec 15.

5.

L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells.

Li Z, Oganesyan D, Mooney R, Rong X, Christensen MJ, Shahmanyan D, Perrigue PM, Benetatos J, Tsaturyan L, Aramburo S, Annala AJ, Lu Y, Najbauer J, Wu X, Barish ME, Brody DL, Aboody KS, Gutova M.

Stem Cell Reports. 2016 Sep 13;7(3):483-495. doi: 10.1016/j.stemcr.2016.07.013. Epub 2016 Aug 18.

6.

Histone demethylase JMJD3 at the intersection of cellular senescence and cancer.

Perrigue PM, Najbauer J, Barciszewski J.

Biochim Biophys Acta. 2016 Apr;1865(2):237-44. doi: 10.1016/j.bbcan.2016.03.002. Epub 2016 Mar 5. Review.

PMID:
26957416
7.

Planarians as a model of aging to study the interaction between stem cells and senescent cells in vivo.

Perrigue PM, Najbauer J, Jozwiak AA, Barciszewski J, Aboody KS, Barish ME.

Pathobiol Aging Age Relat Dis. 2015 Dec 10;5:30052. doi: 10.3402/pba.v5.30052. eCollection 2015.

8.

The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines.

Perrigue PM, Silva ME, Warden CD, Feng NL, Reid MA, Mota DJ, Joseph LP, Tian YI, Glackin CA, Gutova M, Najbauer J, Aboody KS, Barish ME.

Mol Cancer Res. 2015 Apr;13(4):636-50. doi: 10.1158/1541-7786.MCR-13-0268. Epub 2015 Feb 4.

9.

Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin.

Najbauer J, Kraljik N, Németh P.

Pathol Oncol Res. 2014 Oct;20(4):789-97. doi: 10.1007/s12253-014-9837-z. Epub 2014 Aug 29. Review.

PMID:
25168767
10.

Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.

Metz MZ, Gutova M, Lacey SF, Abramyants Y, Vo T, Gilchrist M, Tirughana R, Ghoda LY, Barish ME, Brown CE, Najbauer J, Potter PM, Portnow J, Synold TW, Aboody KS.

Stem Cells Transl Med. 2013 Dec;2(12):983-92. doi: 10.5966/sctm.2012-0177. Epub 2013 Oct 28.

11.

Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use.

Gutova M, Frank JA, D'Apuzzo M, Khankaldyyan V, Gilchrist MM, Annala AJ, Metz MZ, Abramyants Y, Herrmann KA, Ghoda LY, Najbauer J, Brown CE, Blanchard MS, Lesniak MS, Kim SU, Barish ME, Aboody KS, Moats RA.

Stem Cells Transl Med. 2013 Oct;2(10):766-75. doi: 10.5966/sctm.2013-0049. Epub 2013 Sep 6.

12.

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

Aboody KS, Najbauer J, Metz MZ, D'Apuzzo M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats RA, Garcia E, Aramburo S, Valenzuela VV, Frank RT, Barish ME, Brown CE, Kim SU, Badie B, Portnow J.

Sci Transl Med. 2013 May 8;5(184):184ra59. doi: 10.1126/scitranslmed.3005365.

13.

Cellular host responses to gliomas.

Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, Myers SM, Gutova M, Frank RT, Miletic H, Kendall SE, Glackin CA, Bjerkvig R, Aboody KS.

PLoS One. 2012;7(4):e35150. doi: 10.1371/journal.pone.0035150. Epub 2012 Apr 23.

14.

Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.

Gutova M, Shackleford GM, Khankaldyyan V, Herrmann KA, Shi XH, Mittelholtz K, Abramyants Y, Blanchard MS, Kim SU, Annala AJ, Najbauer J, Synold TW, D'Apuzzo M, Barish ME, Moats RA, Aboody KS.

Gene Ther. 2013 Feb;20(2):143-50. doi: 10.1038/gt.2012.12. Epub 2012 Mar 8.

15.

Human neural stem cell tropism to metastatic breast cancer.

Zhao D, Najbauer J, Annala AJ, Garcia E, Metz MZ, Gutova M, Polewski MD, Gilchrist M, Glackin CA, Kim SU, Aboody KS.

Stem Cells. 2012 Feb;30(2):314-25. doi: 10.1002/stem.784.

16.

Strategies for enhancing antibody delivery to the brain.

Frank RT, Aboody KS, Najbauer J.

Biochim Biophys Acta. 2011 Dec;1816(2):191-8. doi: 10.1016/j.bbcan.2011.07.002. Epub 2011 Jul 8. Review.

PMID:
21767610
17.

Concise review: stem cells as an emerging platform for antibody therapy of cancer.

Frank RT, Najbauer J, Aboody KS.

Stem Cells. 2010 Nov;28(11):2084-7. doi: 10.1002/stem.513. Review.

18.

Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.

Frank RT, Edmiston M, Kendall SE, Najbauer J, Cheung CW, Kassa T, Metz MZ, Kim SU, Glackin CA, Wu AM, Yazaki PJ, Aboody KS.

PLoS One. 2009 Dec 15;4(12):e8314. doi: 10.1371/journal.pone.0008314.

19.

Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme.

Gutova M, Najbauer J, Chen MY, Potter PM, Kim SU, Aboody KS.

Curr Stem Cell Res Ther. 2010 Sep;5(3):273-6.

PMID:
19951251
20.

Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.

Thu MS, Najbauer J, Kendall SE, Harutyunyan I, Sangalang N, Gutova M, Metz MZ, Garcia E, Frank RT, Kim SU, Moats RA, Aboody KS.

PLoS One. 2009 Sep 29;4(9):e7218. doi: 10.1371/journal.pone.0007218.

21.

Neural stem cell tropism to glioma: critical role of tumor hypoxia.

Zhao D, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, Kim SU, Aboody KS.

Mol Cancer Res. 2008 Dec;6(12):1819-29. doi: 10.1158/1541-7786.MCR-08-0146.

22.

Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.

Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.

Stem Cells. 2008 Jun;26(6):1406-13. doi: 10.1634/stemcells.2008-0141. Epub 2008 Apr 10.

23.

Stem and progenitor cell-mediated tumor selective gene therapy.

Aboody KS, Najbauer J, Danks MK.

Gene Ther. 2008 May;15(10):739-52. doi: 10.1038/gt.2008.41. Epub 2008 Mar 27. Review. Erratum in: Gene Ther. 2008 Jul;15(14):1072.

PMID:
18369324
24.

Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling.

Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li S, Bowers M, Garcia E, Kim SU, Barish ME, Aboody KS, Glackin CA.

Stem Cells. 2008 Jun;26(6):1575-86. doi: 10.1634/stemcells.2007-0887. Epub 2008 Mar 13.

25.

The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007.

Rajasekhar VK, Dalerba P, Passegué E, Lagasse E, Najbauer J.

Stem Cells. 2008 Jan;26(1):292-8. Epub 2007 Oct 25.

26.

Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.

Brown CE, Vishwanath RP, Aguilar B, Starr R, Najbauer J, Aboody KS, Jensen MC.

J Immunol. 2007 Sep 1;179(5):3332-41.

27.

Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.

Lin D, Najbauer J, Salvaterra PM, Mamelak AN, Barish ME, Garcia E, Metz MZ, Kendall SE, Bowers M, Kateb B, Kim SU, Johnson M, Aboody KS.

Neuroimage. 2007;37 Suppl 1:S18-26. Epub 2007 May 13.

PMID:
17560798
28.

Identification of uPAR-positive chemoresistant cells in small cell lung cancer.

Gutova M, Najbauer J, Gevorgyan A, Metz MZ, Weng Y, Shih CC, Aboody KS.

PLoS One. 2007 Feb 28;2(2):e243.

29.

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.

Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz MZ, Najbauer J, Potter PM, Aboody KS.

Cancer Res. 2007 Jan 1;67(1):22-5.

30.

Development of a tumor-selective approach to treat metastatic cancer.

Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM, Danks MK.

PLoS One. 2006 Dec 20;1:e23.

31.

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.

Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM, Perides G.

Neuro Oncol. 2006 Apr;8(2):119-26. Epub 2006 Mar 8.

32.

Opinion: the origin of the cancer stem cell: current controversies and new insights.

Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ.

Nat Rev Cancer. 2005 Nov;5(11):899-904. Review. Erratum in: Nat Rev Cancer. 2005 Dec;5(12):995.

PMID:
16327766
33.

Upregulation of complement inhibitors in association with vulnerable cells following contusion-induced spinal cord injury.

Anderson AJ, Najbauer J, Huang W, Young W, Robert S.

J Neurotrauma. 2005 Mar;22(3):382-97.

PMID:
15785233
34.

Internucleosomal DNA fragmentation during deprived and non-deprived olfactory development.

Najbauer J, Yan XX, Leon M.

Brain Res. 2002 Feb 1;926(1-2):118-25.

PMID:
11814413
35.

Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain.

Yan XX, Najbauer J, Woo CC, Dashtipour K, Ribak CE, Leon M.

J Comp Neurol. 2001 Apr 23;433(1):4-22.

PMID:
11283945
36.
37.

Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo.

Najbauer J, Orpiszewski J, Aswad DW.

Biochemistry. 1996 Apr 23;35(16):5183-90.

PMID:
8611502
38.

Olfactory experience modulates Bcl-2 expression in the developing olfactory bulb.

Najbauer J, Ibrahim E, Leon M.

Neuroreport. 1995 Dec 29;7(1):197-200.

PMID:
8742450
39.

Olfactory experience modulated apoptosis in the developing olfactory bulb.

Najbauer J, Leon M.

Brain Res. 1995 Mar 20;674(2):245-51.

PMID:
7796103
41.
42.

Analysis of stable protein methylation in cultured cells.

Najbauer J, Johnson BA, Aswad DW.

Arch Biochem Biophys. 1992 Feb 14;293(1):85-92.

PMID:
1731643
43.

Amplification and detection of substrates for protein carboxyl methyltransferases in PC12 cells.

Najbauer J, Johnson BA, Aswad DW.

Anal Biochem. 1991 Sep 2;197(2):412-20.

PMID:
1785697
46.

Non-specific peroxidase (donor: H2O2-oxidoreductase, EC 1.11.1.7) activity in multiple sclerosis.

Najbauer J, Vécsei L, Pálffy G.

Acta Med Hung. 1990;47(3-4):129-33.

PMID:
1966628
47.

Positive autoradiographic findings in brains of four MS patients.

Najbauer J, Pálffy G, Kuntár L.

Acta Neurol Scand. 1989 Jun;79(6):476-81.

PMID:
2782028
49.

An in vitro micromethod for the quantitative assessment of central demyelination.

Watson CM, Najbauer J, Owen SJ, Davison AN.

J Neurochem. 1988 May;50(5):1469-77.

PMID:
2452236
50.

Supplemental Content

Loading ...
Support Center